Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. - Wikidata - awgldk - TriplyDB

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

http://www.wikidata.org/entity/Q34231127

about

Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): a network meta-analysis Current Management of Alcoholic Hepatitis and Future Therapies New treatment options for alcoholic hepatitis Managing alcoholic liver disease Update on Alcoholic Hepatitis Zebrafish: an important tool for liver disease research Alcoholic liver disease: pathogenesis, management, and novel targets for therapy Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease Alcoholic hepatitis: a comprehensive review of pathogenesis and treatment Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders Emerging concepts in alcoholic hepatitis Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.New drug targets for alcoholic liver disease.Combination therapy: New hope for alcoholic hepatitis?New therapeutic targets in alcoholic hepatitis.Alcoholic hepatitis and concomitant hepatitis C virus infection.Pharmacotherapy for alcoholic patients with alcoholic liver disease Alcoholic liver disease: treatment Alcoholic hepatitis: current challenges and future directions.Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.N-acetylcysteine inhibits the up-regulation of mitochondrial biogenesis genes in livers from rats fed ethanol chronically.Cell death and cell death responses in liver disease: mechanisms and clinical relevance Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.Advances in alcoholic liver disease: An update on alcoholic hepatitis Molecular targets in the treatment of alcoholic hepatitis.Management of alcoholic hepatitis: Current concepts.Doubly blind: a systematic review of gender in randomised controlled trials.Alcoholic Hepatitis: Steroids vs. Pentoxifylline Pathogenesis and Management of Alcoholic Liver Disease.KASL clinical practice guidelines: management of alcoholic liver disease Trends in the management and burden of alcoholic liver disease.Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.Infections in severe alcoholic hepatitis.Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA Alcoholic hepatitis: diagnosis and management in 2012.

P2860

Q24186882-544A8BEC-072D-4832-9D3A-3F61010CC1D7 Q26746544-5526505B-E42C-4306-B748-B7C3EB52AB35 Q26751402-4359D046-9223-48EA-BEFF-80D74E861FDC Q26777480-0562161F-7B62-4C77-8241-43F5BB1D4BF6 Q26779121-4DB322EF-C3C0-4822-93C3-B407FC10B61F Q26796338-054FA04F-E8ED-4C9B-97AC-A50540908502 Q26861620-D9F61D7A-EF6C-4E62-BB63-B6315B1FC6F1 Q27027380-A47C6C72-DA00-4A56-92F4-92A660CF35A0 Q27027418-61B6855F-D63D-4B65-BF04-AAF7523FE2D4 Q28073542-AFA9CAC2-1D69-478A-A0E8-2F25C77BF7F9 Q28081726-1C8DCC11-4BDB-4F07-BE8F-A4FB12FFC04F Q30234425-87296406-131B-4EA2-BE2F-04964B03243B Q30234560-31AAE156-1AE1-429D-A4E5-1ADE685D1B90 Q33587538-58AA90DE-A981-4D3B-B52E-61003D06F930 Q33746508-DFB02745-5138-4B2F-AF1B-886B99C0D19F Q33746519-5EECE205-FE0D-4E99-840A-2D711ED06E0A Q33757267-DE42B243-45CF-473B-B29A-8351305AC8DA Q34168404-AC7D8C08-6540-44BE-9682-53C074D97B29 Q34223054-97EEB477-B105-41C1-8AD7-0DCB4592630A Q34255479-A7C2C447-A110-4729-ADAC-71C55260D569 Q34354286-27F3DB52-F3BF-4FBB-B26E-D163945651DC Q34404386-80A4A665-1F3F-4F6D-9856-08FF184FAE8F Q34941244-D23410AF-408E-4C4D-A8ED-3EA7E929B056 Q35938040-419F528C-F7AD-46F7-920B-CE6FA0C3F530 Q36038296-C2C39DE8-9C1C-4071-977E-58EB09190D37 Q36269638-DC853DCA-8443-4D2A-9472-58C64FA15491 Q36351877-8119BDDA-FDBC-4DEE-9212-08F48567216A Q36561560-494AA63D-ACB0-41D5-9A35-2B7A5A3EFCB8 Q36805845-CF8D4DB8-DA63-44DF-AB72-6E659A2E6B17 Q36899751-105B2C81-0886-4D17-8958-2812504D8077 Q37011836-F1F0B827-BF0F-401B-85D7-CBEAEBE481EE Q37229858-1C6BFAB5-5E4C-4DCB-A279-4EB6895FFC0A Q37237035-2018DBCB-0226-4EA3-A6C8-4ADBA2D1267D Q37421502-49368071-9CF3-4260-9DD2-57A9CD06E0E5 Q37424578-C4ABB012-6947-4A2F-B31D-9C68F39ED73B Q37619758-F3A1B3FA-7DDA-4690-A77A-D6D77008B0B0 Q37657099-661CAD54-708A-413F-8BEE-8800CE2E71C0 Q37696026-FD371D44-9539-4D17-A2E2-8E44FD5D8EFD Q37728503-FF615DDF-3CEC-411D-8718-6546B9275B68 Q38067131-73C01DA1-C002-46BC-BC37-8C0E8E28F7BA

P2860

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

http://www.wikidata.org/entity/Q34231127

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@ast

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@en

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@nl

type

label

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@ast

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@en

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@nl

prefLabel

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@ast

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@en

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@nl

P1433

Q34231127-C3D52BBB-F5A8-449D-B002-1879DECFB3B7

P1476

Q34231127-FDAB0731-F73B-4406-A86A-761245EF99A6

P2093

Q34231127-0B0A2563-7487-467F-B835-9F432A98820F

Q34231127-0D1EC961-67BC-44C1-9DA2-DA287EB9A87A

Q34231127-14537A41-FDE7-4082-85BD-73CFC7FEFD26

Q34231127-38DA6C0E-7B22-4FBD-B414-577BCB4BEA54

Q34231127-41EC1666-AC14-47A3-BAD3-AEDA0F1B4909

Q34231127-5910F814-A289-4075-92B6-0E2B12FA315B

Q34231127-6BD4AE74-4E41-479B-B414-508E4A4FD0EA

Q34231127-7A9181F7-E09E-42F6-B3AC-A6951B0B5D60

Q34231127-7CD39D9F-7995-491D-8054-F8E9EFBE1C9B

Q34231127-948C0986-57A6-406D-A4AE-7EDD57A5A03B

P304

Q34231127-862681EB-418F-46A2-A251-CCC302667A74

P31

Q34231127-EC8A4C8B-F2AE-4280-B6C1-789A8D48FABE

P356

Q34231127-54D19382-A5FA-4A3D-B3E9-B620FA6FC382

P407

Q34231127-BF9B4DFD-B6C3-4C3D-963B-7FA227FCCA0D

P433

Q34231127-D76B623C-36C5-4D12-B079-9EE48790A918

P478

Q34231127-01CB6D6E-4739-4A6A-98AF-CE8B5C6F8BE1

P577

Q34231127-18F3A394-2279-4A6A-9DA3-85DF14901497

P5875

Q34231127-E6E0FF21-8B59-4613-B803-6BB1D6A15302

P698

Q34231127-BDD10C63-4258-4757-A1D1-4D1D2B03A5B8

P356

P1433

The New England Journal of Medicine

P1476

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

@en

P2093

AAH-NAC Study Group

http://www.w3.org/2001/XMLSchema#string

Abdeslam Bental

http://www.w3.org/2001/XMLSchema#string

Blaise Tramier

http://www.w3.org/2001/XMLSchema#string

Brigitte Bernard-Chabert

http://www.w3.org/2001/XMLSchema#string

Denis Chatelain

http://www.w3.org/2001/XMLSchema#string

Eric Nguyen-Khac

http://www.w3.org/2001/XMLSchema#string

François Dewaele

http://www.w3.org/2001/XMLSchema#string

Hervé Tossou

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Dupas

http://www.w3.org/2001/XMLSchema#string

Marie-Astrid Piquet

http://www.w3.org/2001/XMLSchema#string

P304

1781-1789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1101214

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

365

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51787463

http://www.w3.org/2001/XMLSchema#string

P698

22070475

http://www.w3.org/2001/XMLSchema#string